Induction of platelet thrombi by bacteria and antibodies

Blood

Volumn 100, Issue 13, 2002, Pages 4470-4477

  Sjöbring, Ulf ^a,b   Ringdahl, Ulrika ^a,b   Ruggeri, Zaverio M ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FIBRINOGEN; IMMUNOGLOBULIN G; INTEGRIN; PLASMA PROTEIN;

ARTICLE; BACTERIUM; BINDING AFFINITY; CELL ACTIVATION; CELL ASSAY; CELL SURFACE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; INFECTION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SURFACE PROPERTY; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOGENESIS; THROMBUS;

EID: 0037114630     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0069     Document Type: Article

References (53)

1. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657-666.
2. Erickson PR, Herzberg MC. A collagen-like immunodeterminant on the surface of Streptococcus sanguis induces platelet aggregation. J Immunol. 1987;138:3360-3366.
3. Kurpiewski GE, Forrester LJ, Campbell BJ, Barrett JT. Platelet aggregation by Streptococcus pyogenes. Infect Immun. 1983;39:704-708.
4. Sullam PM, Bayer AS, Foss WM, Cheung AL. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun. 1996;64:4915-4921.
5. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in western Norway: Incidence and clinical features. Lancet. 1994;344:1111-1115.
6. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586-592.
7. Barker FG, Leppard BJ, Seal DV. Streptococcal necrotising fasciitis: Comparison between histological and clinical features. J Clin Pathol. 1987;40:335-341.
8. Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis: The use of frozen-section biopsy. N Engl J Med. 1984;310:1689-1693.
9. Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation. 1999;99:2791-2797.
10. Durack DT. Experimental bacterial endocarditis, IV: Structure and evolution of very early lesions. J Pathol. 1975;115:81-89.
11. Baumgartner JN, Cooper SL. Influence of thrombus components in mediating Staphylococcus aureus adhesion to polyurethane surfaces. J Biomed Mater Res. 1998;40:660-670.
12. Hagelskjaer KL, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis. 2000;31:524-532.
13. Plemmons RM, Dooley DP, Longfield RN. Septic thrombophlebitis of the portal vein (pylephlebitis): Diagnosis and management in the modern era. Clin Infect Dis. 1995;21:1114-1120.
14. Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood. 1999;94:172-178.
15. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest. 1998;102:550-560.
16. Kihlberg B-M, Collin M, Olsen A, Björck L. Protein H, an antiphagocytic surface protein in Streptococcus pyogenes. Infect Immun. 1999;67:1708-1714.
17. Johnsson E, Berggard K, Kotarsky H, et al. Role of the hypervariable region in streptococcal M proteins: Binding of a human complement inhibitor. J Immunol. 1998;161:4894-4901.
18. McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 1994;11:237-248.
19. Ringdahl U, Svensson HG, Kotarsky H, Gustafsson M, Weineisen M, Sjobring U. A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol. 2000;37:1318-1326.
20. O'Connell DP, Nanavaty T, McDevitt D, Gurusiddappa S, Hook M, Foster TJ. The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem. 1998;273:6821-6829.
21. Akesson P, Schmidt KH, Cooney J, Bjorck L. M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J. 1994;300:877-886.
22. Kazal LA, Amsel S, Miller OP, Tocantins LM. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Natl Acad Sci U S A. 1963;113:989-994.
23. Niiya K, Hodson E, Bader R, et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation: Relationship to the binding of fibrinogen and platelet aggregation. Blood. 1987;70:475-483.
24. Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J Clin Invest. 1983;72:1-12.
25. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein lb: Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem. 1986;261:12579-12585.
26. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289-297.
27. Usami S, Chen HH, Zhao Y, Chien S, Skalak R. Design and construction of a linear shear stress flow chamber. Ann Biomed Eng. 1993;21:77-83.
28. Whatmore AM, Kapur V, Sullivan DJ, Musser JM, Kehoe MA. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol Microbiol. 1994;14:619-631.
29. Looney RJ, Abraham GN, Anderson CL. Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J Immunol. 1986;136:1641-1647.
30. Anderson CL, Chacko GW, Osborne JM, Brandt JT. The Fc receptor for immunoglobulin G (Fc gamma RII) on human platelets. Semin Thromb Hemost. 1995;21:1-9.
31. Deckmyn H, Vanhoorelbeke K, Peerlinck K. Inhibitory and activating human antiplatelet antibodies. Baillieres Clin Haematol. 1998;11:343-359.
32. Beumer S, IJsseldijk MJ, de Groot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: Dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. Blood. 1994;84:3724-3733.
33. Hawiger J, Kloczewiak M, Timmons S, Strong D, Doolittle RF. Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Ann N Y Acad Sci. 1983;408:521-535.
34. Zimmerman TS, Spiegelberg HL. Pneumococcus-induced serotonin release from human platelets: Identification of the participating plasma/serum factor as immunoglobulin. J Clin Invest. 1975;56:828-834.
35. Ford I, Douglas CWI, Cox D, Rees DGC, Heath J, Preston FE. The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis. Br J Haematol. 1997;97:737-746.
36. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med. 2001;29:S48-S52.
37. Wada H, Yamamuro M, Inoue A, et al. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis - Toward a distinction between uncompensated overt DIC and compensated non-overt DIC. Thromb Haemost. 2001;86:1489-1494.
38. Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest. 1993;91:2850-2856.
39. Osterud B. The role of platelets in decrypting monocyte tissue factor. Semin Hematol. 2001;38(suppl 12):2-5.
40. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95:930-935.
41. Hinshaw LB, Emerson TE Jr, Taylor FB Jr, et al. Lethal Staphylococcus aureus-induced shock in primates: Prevention of death with anti-TNF antibody. J Trauma. 1992;33:568-573.
42. Herwald H, Collin M, Muller-Esterl W, Bjorck L. Streptococcal cysteine proteinase releases kinins: A virulence mechanism. J Exp Med. 1996;184:665-673.
43. Taylor FB Jr, Bryant AE, Blick KE, et al. Staging of the baboon response to group A streptococci administered intramuscularly: A descriptive study of the clinical symptoms and clinical chemical response patterns. Clin Infect Dis. 1999;29:167-177.
44. Hinshaw LB, Taylor FB Jr, Chang AC, et al. Staphylococcus aureus-induced shock: A pathophysiologic study. Circ Shock. 1988;26:257-265.
45. Taylor SM, Reilly MP, Schreiber AD, Chien P, Tuckosh JR, McKenzie SE. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: The interplay among antibody, spleen, and Fc receptor. Blood. 2000;96:4254-4260.
46. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37:239-248.
47. Warkentin TE. Heparin-induced thrombocytopenia: A ten-year retrospective. Annu Rev Med. 1999;50:129-147.
48. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis. 1997;25:951-968.
49. Krijgsveld J, Zaat SA, Meeldijk J, et al. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem. 2000;275:20374-20381.
50. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J. 1999;138:S534-S536.
51. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: A risk factor for coronary heart disease? Ann Periodontol. 1998;3:127-141.
52. Pellicano R, Oliaro E, Gandolfo N, et al. Ischemic cardiovascular disease and Helicobacter pylori. Where is the link? J Cardiovasc Surg. 2000;41:829-833.
53. Lee SY. Postantibiotic effects and postantibiotic sub-MIC effects of amoxicillin on Streptococcus gordonii and Streptococcus sanguis. J Chemother. 2000;12:379-384.